Envista Holdings Corporation $NVST Stake Reduced by Clarkston Capital Partners LLC

Clarkston Capital Partners LLC reduced its stake in shares of Envista Holdings Corporation (NYSE:NVST) by 2.4% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 4,211,735 shares of the company’s stock after selling 105,520 shares during the period. Envista makes up about 2.1% of Clarkston Capital Partners LLC’s holdings, making the stock its 16th largest holding. Clarkston Capital Partners LLC’s holdings in Envista were worth $91,437,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Tudor Investment Corp ET AL bought a new position in shares of Envista in the third quarter worth $1,664,000. First Eagle Investment Management LLC bought a new position in shares of Envista in the third quarter worth $4,329,000. Massachusetts Financial Services Co. MA grew its stake in shares of Envista by 15.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,349,874 shares of the company’s stock worth $72,726,000 after purchasing an additional 444,725 shares in the last quarter. Jupiter Asset Management Ltd. grew its stake in shares of Envista by 24.6% in the third quarter. Jupiter Asset Management Ltd. now owns 1,349,042 shares of the company’s stock worth $27,480,000 after purchasing an additional 266,671 shares in the last quarter. Finally, Fox Run Management L.L.C. bought a new position in shares of Envista in the third quarter worth $880,000.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Barclays decreased their price target on Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday. Robert W. Baird increased their price target on Envista from $30.00 to $31.00 and gave the stock an “outperform” rating in a research note on Thursday, May 7th. Weiss Ratings cut Envista from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Wall Street Zen cut Envista from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 9th. Finally, Citigroup initiated coverage on Envista in a research note on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 price target for the company. Six investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $28.67.

Envista Trading Up 0.2%

Shares of NVST stock opened at $24.54 on Friday. The stock has a 50-day simple moving average of $25.02 and a 200 day simple moving average of $24.71. Envista Holdings Corporation has a fifty-two week low of $18.25 and a fifty-two week high of $30.42. The stock has a market capitalization of $3.99 billion, a P/E ratio of 59.86, a P/E/G ratio of 1.39 and a beta of 0.88. The company has a quick ratio of 2.06, a current ratio of 2.44 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Envista had a return on equity of 7.11% and a net margin of 2.41%.The business had revenue of $705.50 million during the quarter, compared to analysts’ expectations of $680.04 million. During the same quarter last year, the business posted $0.24 earnings per share. The company’s quarterly revenue was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, sell-side analysts expect that Envista Holdings Corporation will post 1.42 earnings per share for the current fiscal year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.